Oscar Health (OSCR) is up 5.5% today. Here is some analysis on what might have caused this price movement.
Analysis: The most likely driver is continued buying after Oscar Health’s early-August second-quarter update, which pointed to strong profitability and a higher full-year outlook. There does not appear to be a major new company-specific filing tied directly to today’s move, so part of the gain could be momentum as investors continue to reprice the stronger earnings picture.
Details:
Sources:
Oscar Health Investor Relations, SEC, Yahoo Finance
Disclaimer: This price movement analysis was generated with the help of AI. Please double-check the information provided for mistakes.
$OSCR Insider Trading Activity
$OSCR insiders have traded $OSCR stock on the open market 42 times in the past 6 months. Of those trades, 1 have been purchases and 41 have been sales.
Here’s a breakdown of recent trading of $OSCR stock by insiders over the last 6 months:
- MARK T BERTOLINI (Chief Executive Officer) has made 1 purchase buying 1,000,000 shares for an estimated $11,920,000 and 8 sales selling 2,445,306 shares for an estimated $70,679,399.
- MARIO SCHLOSSER has made 0 purchases and 18 sales selling 1,133,455 shares for an estimated $32,741,905.
- RICHARD SCOTT BLACKLEY (Chief Financial Officer) has made 0 purchases and 6 sales selling 260,904 shares for an estimated $6,021,862.
- ADAM MCANANEY (Chief Legal Officer) has made 0 purchases and 3 sales selling 28,569 shares for an estimated $466,845.
- JANET LIANG (President, Oscar Insurance) has made 0 purchases and 3 sales selling 19,928 shares for an estimated $373,512.
- VICTORIA BALTRUS (Chief Accounting Officer) has made 0 purchases and 3 sales selling 6,161 shares for an estimated $95,519.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$OSCR Hedge Fund Activity
We have seen 240 institutional investors add shares of $OSCR stock to their portfolio, and 179 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- FMR LLC added 3,799,751 shares (+317.0%) to their portfolio in Q2 2026, for an estimated $108,368,898
- RENAISSANCE TECHNOLOGIES LLC added 3,284,500 shares (+inf%) to their portfolio in Q2 2026, for an estimated $93,673,940
- BLACKROCK, INC. added 3,277,889 shares (+18.9%) to their portfolio in Q2 2026, for an estimated $93,485,394
- BIT CAPITAL GMBH removed 2,903,464 shares (-45.9%) from their portfolio in Q2 2026, for an estimated $82,806,793
- JANE STREET GROUP, LLC removed 2,877,721 shares (-49.8%) from their portfolio in Q1 2026, for an estimated $33,007,459
- SIXTH STREET PARTNERS MANAGEMENT COMPANY, L.P. added 2,119,863 shares (+inf%) to their portfolio in Q2 2026, for an estimated $60,458,492
- AMERICAN CENTURY COMPANIES INC added 2,025,886 shares (+28.8%) to their portfolio in Q2 2026, for an estimated $57,778,268
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
$OSCR Price Targets
Multiple analysts have issued price targets for $OSCR recently. We have seen 4 analysts offer price targets for $OSCR in the last 6 months, with a median target of $19.5.
Here are some recent targets:
- Andrew Mok from Barclays set a target price of $35.0 on 06/10/2026
- Michael Ha from Baird set a target price of $19.0 on 05/07/2026
- Jonathan Yong from UBS set a target price of $20.0 on 05/07/2026
- David Windley from Jefferies set a target price of $16.0 on 04/20/2026
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
